Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

MLA

Atakan Tekinalp, et al. “Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye.” Turkish Journal of Hematology, vol. 40, no. 4, Dec. 2023, pp. 242–50. EBSCOhost, https://doi.org/10.4274/tjh.galenos.2023.2023.0029.

APA

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz, Esra Terzi Demirsoy, Vildan Gürsoy, Müzeyyen Aslaner Ak, Metin Bağcı, Sema Seçilmiş, Fatma Keklik Karadağ, Ayşe Oruç Uysal, Ali Doğan, Sinan Demircioğlu, Haşim Atakan Erol, Ceyda Aslan, Fahir Özkalemkaş, Şehmus Ertop, Mehmet Dağlı, Mehmet Sinan Dal, Güray Saydam, … Özcan Çeneli. (2023). Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye. Turkish Journal of Hematology, 40(4), 242–250. https://doi.org/10.4274/tjh.galenos.2023.2023.0029

Chicago

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz, Esra Terzi Demirsoy, Vildan Gürsoy, Müzeyyen Aslaner Ak, Metin Bağcı, et al. 2023. “Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye.” Turkish Journal of Hematology 40 (4): 242–50. doi:10.4274/tjh.galenos.2023.2023.0029.